Clinical Trial Update: Trastuzumab Based Therapy in HER2 Positive AGC

View source ↗

Summary

A trial evaluating trastuzumab-based therapy for HER2-positive gastric adenocarcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Adenocarcinoma

Drugs mentioned

• Trastuzumab (trastuzumab)

Snippet

Sponsor: Shanghai Zhongshan Hospital | Conditions: Gastric Adenocarcinoma | Status: COMPLETED